BX Swiss TOP 30 CHF
1.268,93
PKT
-17,93
PKT
-1,39
%
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
Datum | Rating | Analyst | |
---|---|---|---|
02.10.18 | UBS buy | HSBC | |
02.10.18 | UBS buy | HSBC | |
02.10.18 | Nestlé buy | Jefferies & Company Inc. | |
01.10.18 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
01.10.18 | UBS overweight | JP Morgan Chase & Co. | |
28.09.18 | Nestlé buy | Goldman Sachs Group Inc. | |
28.09.18 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
28.09.18 | Roche Hold | Deutsche Bank AG | |
28.09.18 | Novartis Hold | Deutsche Bank AG | |
27.09.18 | ABB (Asea Brown Boveri) buy | Citigroup Corp. | |
26.09.18 | UBS Underweight | Barclays Capital | |
26.09.18 | Zurich Insurance Neutral | UBS AG | |
26.09.18 | UBS overweight | JP Morgan Chase & Co. | |
25.09.18 | Roche overweight | JP Morgan Chase & Co. | |
25.09.18 | Novartis Neutral | UBS AG | |
25.09.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
25.09.18 | Holcim Hold | Kepler Cheuvreux | |
25.09.18 | Swiss Re Hold | Commerzbank AG | |
25.09.18 | Roche overweight | JP Morgan Chase & Co. | |
25.09.18 | Nestlé overweight | JP Morgan Chase & Co. | |
25.09.18 | Givaudan overweight | JP Morgan Chase & Co. | |
24.09.18 | Nestlé market-perform | Bernstein Research | |
24.09.18 | Givaudan verkaufen | Bernstein Research | |
20.09.18 | Novartis Equal weight | Barclays Capital | |
20.09.18 | Nestlé Neutral | BNP PARIBAS | |
20.09.18 | Nestlé overweight | JP Morgan Chase & Co. | |
20.09.18 | Nestlé buy | Goldman Sachs Group Inc. | |
20.09.18 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
19.09.18 | Roche Neutral | UBS AG | |
19.09.18 | Nestlé Underperform | Credit Suisse Group | |
18.09.18 | UBS buy | Deutsche Bank AG | |
18.09.18 | UBS Hold | Deutsche Bank AG | |
14.09.18 | Roche Neutral | UBS AG | |
14.09.18 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
14.09.18 | ABB (Asea Brown Boveri) buy | Société Générale Group S.A. (SG) | |
12.09.18 | Swiss Re Sell | UBS AG | |
12.09.18 | UBS buy | Goldman Sachs Group Inc. | |
12.09.18 | UBS Neutral | Goldman Sachs Group Inc. | |
11.09.18 | Novartis buy | Citigroup Corp. | |
11.09.18 | Novartis Neutral | UBS AG |